Holen Sie sich die Stockscreener-App
90.14
4.58%
-4.33
Handel nachbörslich:
90.14
Schlusskurs vom Vortag:
$94.47
Offen:
$93.91
24-Stunden-Volumen:
1.17M
Relative Volume:
1.25
Marktkapitalisierung:
$5.17B
Einnahmen:
$360.35M
Nettoeinkommen (Verlust:
$-149.57M
KGV:
-30.45
EPS:
-2.96
Netto-Cashflow:
$-81.27M
1W Leistung:
-6.65%
1M Leistung:
+3.02%
6M Leistung:
-19.67%
1J Leistung:
-31.09%
1-Tages-Spanne:
$89.83
$94.14
1-Wochen-Bereich:
$89.83
$97.00
52-Wochen-Spanne:
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Firmenname
Glaukos Corporation
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Vergleichen Sie GKOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
90.14 | 5.39B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Glaukos at Wells Fargo Conference: Strategic Growth and Market Expansion - Investing.com
Will Glaukos Corporation price bounce be sustainableJuly 2025 Earnings & Precise Buy Zone Identification - Newser
Will Glaukos Corporation rebound enough to break even2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
What’s the MACD signal for Glaukos CorporationProduct Launch & AI Powered Market Entry Strategies - khodrobank.com
How to recover losses in Glaukos Corporation stockPortfolio Risk Report & Daily Chart Pattern Signal Reports - Newser
Price momentum metrics for Glaukos Corporation explainedPortfolio Value Report & Reliable Price Breakout Alerts - Newser
Tools to assess Glaukos Corporation’s risk profileTrade Entry Report & High Accuracy Trade Alerts - Newser
Using RSI to spot recovery in Glaukos CorporationExit Point & Weekly Watchlist for Hot Stocks - Newser
Relative strength of Glaukos Corporation in sector analysisJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Published on: 2025-09-03 02:06:26 - Newser
Real time scanner hits for Glaukos Corporation explainedBond Market & Fast Entry and Exit Trade Plans - Newser
Custom strategy builders for tracking Glaukos CorporationTreasury Yields & Fast Entry High Yield Stock Tips - Newser
Real time breakdown of Glaukos Corporation stock performanceJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
News impact scoring models applied to Glaukos Corporation2025 Key Highlights & Detailed Earnings Play Alerts - Newser
Is Glaukos Corporation a speculative investmentWeekly Risk Report & Precise Trade Entry Recommendations - khodrobank.com
Glaukos Builds Dual Growth Engines Amid Market Headwinds - Yahoo Finance
Can swing trading help recover from Glaukos Corporation lossesJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Short interest data insights for Glaukos Corporation2025 Short Interest & Comprehensive Market Scan Insights - Newser
Is Glaukos Corporation benefiting from innovation trendsTrade Entry Report & Real-Time Sentiment Analysis - khodrobank.com
Is Glaukos Corporation affected by consumer sentimentEarnings Miss & Reliable Intraday Trade Plans - khodrobank.com
What analysts say about Glaukos Corporation stock outlookPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser
Order Flow Trends Show Accumulation in Glaukos Corporation getLinesFromResByArray error: size == 0 - kangso.co.kr
Trend Recap: Is Glaukos Corporation benefiting from innovation trendsBuy Signal & Weekly Momentum Stock Picks - khodrobank.com
Is Glaukos Corporation still worth holding after the dipJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Applying Wyckoff theory to Glaukos Corporation stockWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Glaukos Corporation stock trend forecastJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser
Glaukos Corporation Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - thegnnews.com
Will Glaukos Corporation Hold Gains Into CloseBull Run & Verified Momentum Stock Ideas - beatles.ru
Multi factor analysis applied to Glaukos CorporationGlobal Markets & AI Enhanced Trading Alerts - Newser
Detecting price anomalies in Glaukos Corporation with AI2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Finanzdaten der Glaukos Corporation-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):